Intervention 1: Intervention group: They will receive oral apixaban 5-lepixa (manufactured by Actoverco) from day 2 to day 28 after surgery at a dose of 2.5 mg twice daily. The dosage will be adjusted

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Gastric cancerObesity, One-anastomosis gastric bypass surgery. Overweight and obesity

Phase 2

Apixaban vs. Enoxaparin after total gasterectomy in patients with gastric cancer

Active, not recruitingIRCT20220530055031N6

Tehran University of Medical SciencesGastric cancer

Start: 2024-09-22Target: 40Updated: 2025-08-19

Apixaban vs. Enoxaparin bariatric surgery in obese patients

RecruitingIRCT20220530055031N7

Tehran University of Medical SciencesObesity, One-anastomosis gastric bypass surgery. Overweight and obesity

Start: 2024-12-21Target: 40Updated: 2025-01-08